These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37832796)

  • 1. Long-lasting antiseizure effects of chronic intrasubthalamic convection-enhanced delivery of valproate.
    MacKeigan D; Feja M; Meller S; Deking L; Javadova A; Veenhuis A; Felmy F; Gernert M
    Neurobiol Dis; 2023 Oct; 187():106321. PubMed ID: 37832796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic convection-enhanced muscimol delivery into the rat subthalamic nucleus induces antiseizure effects associated with high responder rates.
    Gernert M; MacKeigan D; Deking L; Kaczmarek E; Feja M
    Epilepsy Res; 2023 Feb; 190():107097. PubMed ID: 36736200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic intermittent convection-enhanced delivery of vigabatrin to the bilateral subthalamic nucleus in an acute rat seizure model.
    MacKeigan D; Feja M; Gernert M
    Epilepsy Res; 2024 Jan; 199():107276. PubMed ID: 38091904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of valproate and its major active metabolite E-2-en-valproate on single unit activity of substantia nigra pars reticulata neurons in rats.
    Rohlfs A; Rundfeldt C; Koch R; Löscher W
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1305-14. PubMed ID: 8667191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vigabatrin for focal drug delivery in epilepsy: bilateral microinfusion into the subthalamic nucleus is more effective than intranigral or systemic administration in a rat seizure model.
    Bröer S; Backofen-Wehrhahn B; Bankstahl M; Gey L; Gernert M; Löscher W
    Neurobiol Dis; 2012 May; 46(2):362-76. PubMed ID: 22342648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anticonvulsant response to valproate in kindled rats is correlated with its effect on neuronal firing in the substantia nigra pars reticulata: a new mechanism of pharmacoresistance.
    Töllner K; Wolf S; Löscher W; Gernert M
    J Neurosci; 2011 Nov; 31(45):16423-34. PubMed ID: 22072692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous bilateral infusion of vigabatrin into the subthalamic nucleus: Effects on seizure threshold and GABA metabolism in two rat models.
    Gey L; Gernert M; Löscher W
    Neurobiol Dis; 2016 Jul; 91():194-208. PubMed ID: 26976738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage.
    White HS; Alex AB; Pollock A; Hen N; Shekh-Ahmad T; Wilcox KS; McDonough JH; Stables JP; Kaufmann D; Yagen B; Bialer M
    Epilepsia; 2012 Jan; 53(1):134-46. PubMed ID: 22150444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, anticonvulsant efficacy, and adverse effects of trans-2-en-valproate after acute and chronic administration in amygdala-kindled rats.
    Hönack D; Rundfeldt C; Löscher W
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):187-96. PubMed ID: 1570023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in firing rate of substantia nigra pars reticulata neurons by valproate: influence of different types of anesthesia in rats.
    Löscher W; Rohlfs A; Rundfeldt C
    Brain Res; 1995 Dec; 702(1-2):133-44. PubMed ID: 8846068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
    Abdelmesih SK; Elkhateeb N; Zakaria M; Girgis MY
    Seizure; 2021 Oct; 91():263-270. PubMed ID: 34246881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the pentylenetetrazole seizure threshold test in epileptic mice as surrogate model for drug testing against pharmacoresistant seizures.
    Töllner K; Twele F; Löscher W
    Epilepsy Behav; 2016 Apr; 57(Pt A):95-104. PubMed ID: 26930359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of anticonvulsant efficacy of valproate during prolonged treatment with one and three daily doses or continuous ("controlled release") administration in a model of generalized seizures in rats.
    Löscher W; Hönack D
    Epilepsia; 1995 Sep; 36(9):929-37. PubMed ID: 7649133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
    van Vliet EA; Edelbroek PM; Gorter JA
    Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimum effective sodium valproate dose in genetic generalized epilepsies.
    Marques VD; Hackbart BA; Guilhoto LM; Duarte JTC; Peixoto-Santos JE; Yacubian EMT; Bittar Guaranha MS
    Seizure; 2023 May; 108():53-59. PubMed ID: 37088055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex.
    Gobbi G; Janiri L
    Psychopharmacology (Berl); 2006 Apr; 185(2):255-62. PubMed ID: 16496131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium supplementation enhances the anticonvulsant potential of valproate in pentylenetetrazol-treated rats.
    Safar MM; Abdallah DM; Arafa NM; Abdel-Aziz MT
    Brain Res; 2010 Jun; 1334():58-64. PubMed ID: 20353763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of GABA(A) receptors in subthalamic neurons in vitro: properties of native receptors and inhibition mechanisms.
    Baufreton J; Garret M; Dovero S; Dufy B; Bioulac B; Taupignon A
    J Neurophysiol; 2001 Jul; 86(1):75-85. PubMed ID: 11431489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice.
    Luszczki JJ; Mohamed M; Czuczwar SJ
    Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats.
    Semmes RL; Shen DD
    Epilepsia; 1991; 32(2):232-41. PubMed ID: 2004628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.